Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.

Regional lymph node classification for lung cancer staging. Chest (1997) 5.13

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol (2000) 2.48

Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg (1978) 2.28

The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg (2008) 2.23

18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst (2007) 1.88

Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax (2010) 1.80

Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg (2005) 1.78

Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Ann Thorac Surg (2006) 1.53

Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer (1999) 1.27

Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg (2001) 1.22

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer (2009) 1.17

The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg (1998) 1.16

The TNM staging system and breast cancer. Lancet Oncol (2003) 1.08

Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. World J Surg (2012) 1.07

Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol (2003) 1.06

Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest (2003) 1.04

Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg (2004) 1.01

The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg (1999) 0.94

Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest (1991) 0.91

Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Eur J Surg Oncol (2006) 0.85

Prognostic factors in patients with pathological and N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg (2008) 0.83

Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study. Ann Nucl Med (2011) 0.83

[TNM classification of breast cancer: changes and comments on the 7th edition]. Pathologe (2010) 0.80